blood analyz blood test veterinarian
client offer wide rang chemistri
hematolog immunotherapi test
high-definit digit radiographi
digit ultrasound technolog pair
requir disclosur end report
set compani nice analyst
view current cl king meet event calendar coverag univers
post good quarter includ beat top rais
guidanc quarter specif matter less investor
gear analyst day tuesday may thesi
done admir job go market share
compani longer obscur player
anim health ah space face competitor see
competit threat reiter neutral rate
number report revenu year
year versu year-ago period beat
street ep versu adjust ep last year
look street look
guidanc updat guidanc growth
impli revenu vs prior compani beat
new guidanc essenti leav next three quarter
assumpt intact said also leav room beat back
half year comp get easi diagnost industri
grow heska imag ovp segment perform better
expect
blood diagnost heska companion group includ blood
imag post revenu year year versu
estim year-ago quarter nice rebound
realli tough saw growth declin lab consum
instrument revenu call year-
over-year declin pump order fairli lumpi higher mix
corpor account subscript instrument revenu recogn
point instal
vaccin pharmaceut ovp revenu
beat estim last year
ovp lumpi busi there enough read vi -- vi upsid
annual ovp guidanc addit imag came
growth versu estim
analyst day purpos vagu call want investor
focu analyst day held tuesday may nyc
discuss growth initi includ intern expans new
model rais revenu estim
lower ep forecast account
ep miss also increas revenu project
lower ep forecast
base recent spend
risk includ relianc distributor regul multipl sole supplier
vet industri macro situat price concess competit addit
think abaxi abaxa could get acquir zoeti
elanco part nr
page
